Reverse Settlements: FTC Commissioner, Circuit Judge, Former Solicitor General Debate When A Deal Is Acceptable
Executive Summary
Key players in the battle over reverse settlements between brand name and generic drug manufacturers offered ways to resolve the issue at a recent in-house counsel forum on pharmaceutical antitrust
You may also be interested in...
FTC's Reverse Settlement Campaign May Depend On Congress After Another Court Loss
Suit against Solvay and three generic firms is tossed out of Georgia federal court, but direct purchasers may proceed with claims that defendants filed sham litigation.
Brand/Generic Settlement Bill Advances; Will Debate Come Down To FTC v. CBO?
After clearing the Senate Judiciary Committee on Oct. 15, the next hurdle for legislation that would curtail settlement deals between brand firms and generic challengers may be obtaining a favorable score from the Congressional Budget Office
Reverse Settlements Are Acceptable Under Certain Conditions, DoJ Says
Brand company payments to generic firms to settle infringement suits may not violate antitrust laws if they permit some competition, Department of Justice concludes.